Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 1631 entries
View as:

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01580293 Org: User:
Start: 04/23/12 End: 11/21/19 Due: 11/21/20

Rogaratinib (BAY1163877) Human Mass Balance Study

Phase: N/A Priority: Normal
NCT ID: NCT03484585 Org: User:
Start: 04/06/18 End: 08/09/18 Due: 08/09/19

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

Phase: N/A Priority: Normal
NCT ID: NCT04162795 Org: User:
Start: 11/12/19 End: 11/13/19 Due: 11/13/20

Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients

Phase: N/A Priority: Normal
NCT ID: NCT03535168 Org: User:
Start: 05/29/18 End: 10/11/19 Due: 10/11/20

A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest

Phase: N/A Priority: Normal
NCT ID: NCT04901377 Org: User:
Start: 06/24/21 End: 04/20/23 Due: 04/20/24

A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT05471817 Org: User:
Start: 08/05/22 End: 11/14/22 Due: 11/14/23

Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

Phase: N/A Priority: Normal
NCT ID: NCT02821247 Org: User:
Start: 07/01/16 End: 12/13/19 Due: 12/13/20

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Phase: N/A Priority: Normal
NCT ID: NCT01071122 Org: User:
Start: 01/31/10 End: 02/29/12 Due: 02/28/13

Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT02366949 Org: User:
Start: 02/27/15 End: 04/18/19 Due: 04/18/20

Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain

Phase: N/A Priority: Normal
NCT ID: NCT01453400 Org: User:
Start: 09/27/11 End: 04/06/12 Due: 04/06/13

Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT02924311 Org: User:
Start: 09/21/16 End: 12/06/19 Due: 12/06/20

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01934790 Org: User:
Start: 12/22/13 End: 04/12/17 Due: 04/12/18

Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

Phase: N/A Priority: Normal
NCT ID: NCT01258660 Org: User:
Start: 12/31/06 End: 01/31/08 Due: 01/31/09

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

Phase: N/A Priority: Normal
NCT ID: NCT04356339 Org: User:
Start: 11/24/20 End: 11/11/21 Due: 11/11/22

BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)

Phase: N/A Priority: Normal
NCT ID: NCT00910065 Org: User:
Start: 03/31/11 End: 07/31/14 Due: 07/31/15

Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04081831 Org: User:
Start: 07/31/19 End: 08/25/20 Due: 08/25/21

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Phase: N/A Priority: Normal
NCT ID: NCT02826252 Org: User:
Start: 09/15/16 End: 01/24/17 Due: 01/24/18

Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02168777 Org: User:
Start: 06/23/14 End: 04/05/16 Due: 04/05/17

Acceptability of Long-term Progestin-only Contraception in Europe

Phase: N/A Priority: Normal
NCT ID: NCT00931827 Org: User:
Start: 01/31/08 End: 11/30/11 Due: 11/30/12

A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03412006 Org: User:
Start: 02/02/18 End: 10/10/19 Due: 10/10/20

BAY38-9456 - Supportive Trial for Spinal Injury

Phase: N/A Priority: Normal
NCT ID: NCT00652262 Org: User:
Start: 03/31/04 End: 11/30/04 Due: 11/30/05

Mirena or Conventional Medical Treatment for Menorrhagia

Phase: N/A Priority: Normal
NCT ID: NCT00864136 Org: User:
Start: 11/30/08 End: 11/30/10 Due: 11/30/11

Drug Use Investigation of Gadovist.

Phase: N/A Priority: Normal
NCT ID: NCT02540967 Org: User:
Start: 10/27/15 End: 11/02/17 Due: 11/02/18

Test the Outdoor Usage for Sunscreen Products in Female Adults

Phase: N/A Priority: Normal
NCT ID: NCT02779270 Org: User:
Start: 09/26/15 End: 09/27/15 Due: 09/27/16

To Assess the Safety of a Sunscreen Product

Phase: N/A Priority: Normal
NCT ID: NCT02803320 Org: User:
Start: 05/27/15 End: 05/31/15 Due: 05/31/16